X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
2.930
+0.350 (13.57%)
At close: Aug 13, 2025, 4:00 PM
2.400
-0.530 (-18.09%)
Pre-market: Aug 14, 2025, 9:25 AM EDT
X4 Pharmaceuticals Employees
X4 Pharmaceuticals had 143 employees as of December 31, 2024. The number of employees increased by 50 or 53.76% compared to the previous year.
Employees
143
Change (1Y)
50
Growth (1Y)
53.76%
Revenue / Employee
$229,189
Profits / Employee
-$713,119
Market Cap
33.43M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
XFOR News
- 1 day ago - X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement - GlobeNewsWire
- 2 days ago - X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership - GlobeNewsWire
- 2 months ago - X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA) - GlobeNewsWire
- 2 months ago - X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA - GlobeNewsWire
- 2 months ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress - GlobeNewsWire
- 3 months ago - X4 Pharmaceuticals, Inc. (XFOR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire